Cooperative mechanisms of HIV and opiods in pain pathogenisis
HIV和阿片类药物在疼痛发病机制中的合作机制
基本信息
- 批准号:10665625
- 负责人:
- 金额:$ 59.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-10-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAnalgesicsAstrocytesBehavioralBiopsyCASP1 geneCaspaseCellsChronicClinicalClinical DataCollaborationsElectrophysiology (science)GoalsHIVHIV Envelope Protein gp120HIV-1HIV/AIDSHumanHyperalgesiaInflammasomeInflammation MediatorsInflammatoryInterleukin-1 betaMMP2 geneMatrix MetalloproteinasesMediatingModelingMolecularMolecular AnalysisMorphineMutationOpioidPainPathogenesisPathogenicityPathologicPathologyPathway interactionsPatientsPhenotypePosterior Horn CellsProtein AnalysisProteinsResearchRoleSpinal cord posterior hornTestingUp-RegulationWorkbehavior testcentral sensitizationconditional knockoutdesigndosageimprovedinterdisciplinary approachmechanical allodyniamorphine administrationmouse modelmutantneuroinflammationneuropathologyopioid epidemicopioid overdosepainful neuropathypatch clamppreventreceptorside effectspontaneous painsynergismtherapeutically effectivetranscriptome
项目摘要
ABSTRACT
Opioid-based analgesics are commonly used for temporal relief of severe pain in HIV-1/AIDS patients.
However, recent clinical data show that chronic opioid treatment causes a heightened pain state
(hyperalgesia). This debilitating side effect requires escalating dosages of the analgesics in order to be
effective, and thus may directly contribute to opioid overdose and epidemics. To prevent this clinically
important side effect, it is necessary to understand how chronic use of opioids causes hyperalgesia in HIV
patients. In the HIV-1 gp120 mouse model that recapitulates extensive pain-related pathologies of HIV human
patients, we simulate morphine exacerbation of gp120-induced pain. The goal of this project is to elucidate the
pathogenic mechanism by which morphine potentiates HIV-associated pain. Our prior work reveals that
neuroinflammation in the spinal cord dorsal horn (SDH) is a cardinal neuropathology in HIV patients with
neuropathic pain. Based on our preliminary studies, we propose that neuroinflammation is a convergent
neuropathological mechanism by which gp120 and opioids cooperate to potentiate pathological pain. Our
preliminary studies further show that gp120 and morphine elicit neuroinflammation via overlapped but distinct
molecular pathways. We hypothesize that morphine and gp120 synergize pain pathogenesis by co-activating
the neuroinflammatory pathways. The proposed research is to test this central hypothesis by elucidating the
roles of these pathways in pain pathogenesis induced by gp120 and morphine alone or in combination. We will
use interdisciplinary approaches of protein analysis, single cell transcriptome analysis, whole cell patch
recording and behavioral testing. Results from these studies will significantly improve our understanding of the
mechanism by which morphine exacerbates HIV-associated pain.
摘要
阿片类止痛药通常用于暂时缓解HIV-1/AIDS患者的剧烈疼痛。
然而,最近的临床数据表明,慢性阿片类药物治疗会导致疼痛状态加剧。
(痛觉过敏)。这种使人衰弱的副作用需要增加镇痛剂的剂量才能
有效,因此可能直接导致阿片类药物过量和流行。从临床上防止这种情况发生
重要的副作用,有必要了解长期使用阿片类药物是如何导致艾滋病毒的痛敏的
病人。在HIV-1gp120小鼠模型中,该模型概括了HIV人类广泛的疼痛相关病理
患者,我们模拟吗啡加重gp120诱导的疼痛。这个项目的目标是阐明
吗啡加重HIV相关疼痛的致病机制。我们之前的工作表明
脊髓背角(SDH)神经炎是HIV患者的主要神经病理改变
神经性疼痛。根据我们的初步研究,我们认为神经炎症是一种汇聚性的
Gp120和阿片类药物协同增强病理性疼痛的神经病理机制。我们的
初步研究进一步表明,gp120和吗啡通过重叠但不同的方式引起神经炎症。
分子途径。我们假设吗啡和gp120通过共同激活而协同作用于疼痛发病机制。
神经炎性通路。这项拟议的研究旨在通过阐明
这些通路在gp120和吗啡单独或联合诱导的疼痛发病机制中的作用。我们会
使用蛋白质分析、单细胞转录组分析、全细胞斑块等跨学科方法
录音和行为测试。这些研究的结果将极大地提高我们对
吗啡加重HIV相关疼痛的机制。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neuron Type-Dependent Synaptic Activity in the Spinal Dorsal Horn of Opioid-Induced Hyperalgesia Mouse Model.
- DOI:10.3389/fnsyn.2021.748929
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Kearns A;Jayasi J;Liu X;Wang J;Shi Y;Chung JM;La JH;Tang SJ;Bae C
- 通讯作者:Bae C
Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β.
- DOI:10.3389/fpain.2021.698157
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Boakye PA;Tang SJ;Smith PA
- 通讯作者:Smith PA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIN M CHUNG其他文献
JIN M CHUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIN M CHUNG', 18)}}的其他基金
Cooperative mechanisms of HIV and opiods in pain pathogenisis
HIV和阿片类药物在疼痛发病机制中的合作机制
- 批准号:
10467628 - 财政年份:2021
- 资助金额:
$ 59.49万 - 项目类别:
Cooperative mechanisms of HIV and opiods in pain pathogenisis
HIV和阿片类药物在疼痛发病机制中的合作机制
- 批准号:
10461002 - 财政年份:2021
- 资助金额:
$ 59.49万 - 项目类别:
Cooperative mechanisms of HIV and opiods in pain pathogenisis
HIV和阿片类药物在疼痛发病机制中的合作机制
- 批准号:
10224162 - 财政年份:2019
- 资助金额:
$ 59.49万 - 项目类别:
Cooperative mechanisms of HIV and opiods in pain pathogenisis
HIV和阿片类药物在疼痛发病机制中的合作机制
- 批准号:
9927395 - 财政年份:2019
- 资助金额:
$ 59.49万 - 项目类别:
Cooperative mechanisms of HIV and opiods in pain pathogenisis
HIV和阿片类药物在疼痛发病机制中的合作机制
- 批准号:
10017022 - 财政年份:2019
- 资助金额:
$ 59.49万 - 项目类别:
SYMPATHETIC AND ADRENERGIC DEPENDENCY OF NEUROPATHIC PAIN
神经病理性疼痛的交感神经和肾上腺素依赖性
- 批准号:
6338930 - 财政年份:2000
- 资助金额:
$ 59.49万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 59.49万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 59.49万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 59.49万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 59.49万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 59.49万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 59.49万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 59.49万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 59.49万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 59.49万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 59.49万 - 项目类别: